Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/TRILLIUM-THERAPEUTICS-1411787/news/Trillium-Therapeutics-Announces-Presentation-on-TTI-621-Immune-Checkpoint-Inhibitor-Targeting-CD47-22382109/?utm_source=whatsapp&utm_medium=social&utm_campaign=share